Addition Of Januvia (Sitagliptin) Improves Glycemic Control In Patients Inadequately Controlled By Metformin (MK0431-078)
Status:
Completed
Trial end date:
2009-11-19
Target enrollment:
Participant gender:
Summary
To compare the efficacy of three strategies of lifestyle changes associated with Januvia
(sitagliptin) 100 mg/day in patients with Type 2 Diabetes Mellitus (T2DM) inadequately
controlled by metformin (hemoglobin A1c [HbA1c] 6.5-9%). A difference between the three
strategies of lifestyle changes was expected.